Lab test aims to match brain tumor patients with effective drugs
NCT ID NCT06804655
Summary
This study is testing a personalized approach to find treatments for brain tumors that have stopped responding to standard therapies. Doctors will test tumor cells from surgery in a lab to see which drugs might work best for each patient. The goal is to see if this 'drug-matching' method is practical and can help control tumor growth in people with limited treatment options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cantonal Hospital St Gallen
Sankt Gallen, Canton of St. Gallen, 9007, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University Hospital Basel
Basel, Basel-Landschaft, 4021, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University Hospital Zurich
Zurich, Canton of Zurich, 8091, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.